1. Home
  2. ANY vs CTXR Comparison

ANY vs CTXR Comparison

Compare ANY & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANY
  • CTXR
  • Stock Information
  • Founded
  • ANY N/A
  • CTXR 2007
  • Country
  • ANY United States
  • CTXR United States
  • Employees
  • ANY N/A
  • CTXR N/A
  • Industry
  • ANY Finance: Consumer Services
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • ANY Finance
  • CTXR Health Care
  • Exchange
  • ANY Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • ANY 23.8M
  • CTXR 22.6M
  • IPO Year
  • ANY N/A
  • CTXR N/A
  • Fundamental
  • Price
  • ANY $0.88
  • CTXR $1.25
  • Analyst Decision
  • ANY Strong Buy
  • CTXR Strong Buy
  • Analyst Count
  • ANY 1
  • CTXR 3
  • Target Price
  • ANY $3.00
  • CTXR $53.00
  • AVG Volume (30 Days)
  • ANY 688.9K
  • CTXR 416.2K
  • Earning Date
  • ANY 11-13-2025
  • CTXR 08-12-2025
  • Dividend Yield
  • ANY N/A
  • CTXR N/A
  • EPS Growth
  • ANY N/A
  • CTXR N/A
  • EPS
  • ANY N/A
  • CTXR N/A
  • Revenue
  • ANY $10,831,000.00
  • CTXR N/A
  • Revenue This Year
  • ANY N/A
  • CTXR N/A
  • Revenue Next Year
  • ANY $36.07
  • CTXR $731.60
  • P/E Ratio
  • ANY N/A
  • CTXR N/A
  • Revenue Growth
  • ANY N/A
  • CTXR N/A
  • 52 Week Low
  • ANY $0.36
  • CTXR $0.65
  • 52 Week High
  • ANY $1.90
  • CTXR $12.84
  • Technical
  • Relative Strength Index (RSI)
  • ANY 65.56
  • CTXR 49.82
  • Support Level
  • ANY $0.83
  • CTXR $1.25
  • Resistance Level
  • ANY $0.92
  • CTXR $1.52
  • Average True Range (ATR)
  • ANY 0.07
  • CTXR 0.08
  • MACD
  • ANY 0.01
  • CTXR 0.01
  • Stochastic Oscillator
  • ANY 58.79
  • CTXR 36.59

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Bitcoin Mining and Service and Product. The Bitcoin Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: